Assembly Biosciences, Inc. (ASMB) vs Rezolute, Inc. (RZLT)

A side-by-side comparison of Assembly Biosciences, Inc. and Rezolute, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ASMB vs RZLT

growth of $100 · dividends reinvested · last 10y
ASMB -76.4% (-13.4%/yr)RZLT -94.6% (-25.3%/yr)ASMB compounded faster over this window
0200400600800Start $10020182020202220242026$24$5
ASMB RZLT

ASMB vs RZLT: by the numbers

  • •ASMB is the larger company ($440M vs $416M market cap).

Metrics side by side

Valuation

MetricASMBRZLT
P/E ratio40.33N/A
P/S ratio5.87N/A
P/B ratio1.444.13

Profitability

MetricASMBRZLT
Gross margin99.82%0.00%
Operating margin-11.75%0.00%
Net margin-0.06%0.00%
ROE-0.01%-77.06%
ROIC-2.86%-81.80%

Growth (annualized)

MetricASMBRZLT
Revenue CAGR (5Y)-1.78%N/A
Total return CAGR (5Y)-10.66%-9.57%

Frequently asked

How have ASMB and RZLT total returns compared?
Over the past 10 years, ASMB delivered -13.41% and RZLT delivered -25.30% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.